Fangfei Xiao, Fang Dong, Xiaolu Li, Youran Li, Guangjun Yu, Zhanju Liu, . . . Ting Zhang. (2022). Bifidobacterium longum CECT 7894 Improves the Efficacy of Infliximab for DSS-Induced Colitis via Regulating the Gut Microbiota and Bile Acid Metabolism. Frontiers Media S.A..
Chicago Style (17th ed.) CitationFangfei Xiao, et al. Bifidobacterium Longum CECT 7894 Improves the Efficacy of Infliximab for DSS-Induced Colitis via Regulating the Gut Microbiota and Bile Acid Metabolism. Frontiers Media S.A., 2022.
MLA (9th ed.) CitationFangfei Xiao, et al. Bifidobacterium Longum CECT 7894 Improves the Efficacy of Infliximab for DSS-Induced Colitis via Regulating the Gut Microbiota and Bile Acid Metabolism. Frontiers Media S.A., 2022.
Warning: These citations may not always be 100% accurate.